Background Several studies have found that pharmacists can assist in screening and prevention of osteoporosis by referring patients for bone mineral density scans and counselling on lifestyle changes. In Malaysia, screening osteoporosis in all elderly women is not mandatory due to its cost. One approach to address this gap is to develop a pharmacist-led osteoporosis screening and prevention program. However, there is a paucity of data on the perspectives of Malaysian pharmacists in this area. Objective To explore the perspective of stakeholders (policy makers, doctors, pharmacists, nurses and patients) towards the role of pharmacists in osteoporosis screening and management. Setting A primary care clinic located within a teaching hospital in Kuala Lumpur, Malaysia. Method Patients (n = 20), nurses (n = 10), pharmacists (n = 11), doctors (n = 10) and policy makers (n = 5) were individually interviewed using a semi-structured topic guide. Purposive sampling was used. Interviews were transcribed verbatim and analysed using thematic analysis. Main outcome measure Perspective of stakeholders on the current and future role of pharmacists. Results All participants perceived pharmacists to be suppliers of medication, although there was some recognition of roles in providing medication advice. Nonetheless, these stakeholders were eager for pharmacists to expand their non-dispensing roles towards counselling, creating awareness and screening of osteoporosis. Interviewed pharmacists referred to their current role as ‘robotic dispensers’ and unanimously agreed to spread out to osteoporosis management role. Conclusion Under stakeholders there is a willingness to expand the role of pharmacists in Malaysia to non-dispensing roles, particularly in osteoporosis screening and management.
Malaysia Osteoporosis Pharmacist role Postmenopausal Qualitative Screening
This is a preview of subscription content, log in to check access.
Ministry of Science, Technology and Innovation (MOSTI) fund (06-02-12-SF0183).
Conflicts of interest
All the Authors declares that they have no conflict of interests.
Cooper C, Campion G, Melton LJ. Hip fracture in the elderly: a world-wide projection. Osteoporos Int. 1992;2:285–9.CrossRefPubMedGoogle Scholar
Schneider JK, Nickman NA. Assessment of pharmaceutical care needs in an ambulatory setting. Hosp Pharm. 1994;29:238–42.PubMedGoogle Scholar
Van Boven JFM, Stuurman Bieze AGG, Hiddink EG, Postma MJ, Vegter S. Medication monitoring and optimization: a targeted pharmacist program for effective and cost-effective improvement of chronic therapy adherence. J Manag Care Spec Pharm. 2014;20(8):786–92.PubMedGoogle Scholar
Stuurman-Bieze AGG, Hiddink EG, van Boven JFM, Vegter S. Proactive pharmaceutical care interventions decrease patients’ nonadherence to osteoporosis medication. Osteoporos Int. 2014;25:1807–12.PubMedGoogle Scholar
George PP, Molina JAD, Cheah J, Chan SC, Lim BP. The evolving role of the community pharmacist in chronic disease management—a literature review. Ann Acad Med Singap. 2010;39:861–7.PubMedGoogle Scholar
Lai PSM, Chua SS, Chan SP. Impact of pharmaceutical care on knowledge, quality of life and satisfaction of postmenopausal women with osteoporosis. Int J Clin Pharm. 2013;35(4):629–37.CrossRefPubMedGoogle Scholar
Yuksel N, Majumdar SR, Biggs C, Tsuyuki RT. Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial. Osteoporos Int. 2010;21(3):391–8.CrossRefPubMedGoogle Scholar
Crockett JA, Taylor SJ, McLeod LJ. Patient responses to an integrated service, initiated by community pharmacists, for the prevention of osteoporosis. Int J Pharm Pract. 2008;16(2):65–72.CrossRefGoogle Scholar
McDonough RP, Doucette WR, Kumbera P, Klepser DG. An evaluation of managing and educating patients on the risk of glucocorticoid-induced osteoporosis. Value Health. 2005;8(1):24–31.CrossRefPubMedGoogle Scholar
Ziebland S, McPherson A. Making sense of qualitatative data analysis: an introduction with illustrations from DIPEx (personal experiences of health and illness). Med Educ. 2006;40:405–14.CrossRefPubMedGoogle Scholar
Bazeley P. Analysing qualitative data: more than ‘identifying themes’. Malays J Qual Res. 2009;2:6–22.Google Scholar
Bowen GA. Naturalistic inquiry and the saturation concept: a research note. Qual Res. 2008;8(1):137–52.CrossRefGoogle Scholar
Chen HY, Boore JRP. Translation and back-translation in qualitative nursing research: methodological review. J Clin Nurs. 2009;19:234–9.CrossRefPubMedGoogle Scholar
Australia Department of Health and Ageing WA. Primary healthcare reform in Australia: report to support Australia’s first national primary healthcare strategy. Western Australia: Department of Health and Ageing; 2009.Google Scholar
Farrell B, Pottie K, Woodend K, Yao V, Dolovich L, Kennie N, et al. Shifts in expectations: evaluating physicians’ perceptions as pharmacists become integrated into family practice. J Interprof Care. 2010;24(1):80–9.CrossRefPubMedGoogle Scholar
Blondal AB, Jonsson JS, Sporrong SK, Almarsdottir AB. General practitioners’ perceptions of the current status and pharmacists’ contribution to primary care in Iceland. Int J Clin Pharm. 2017;39(4):945–52.CrossRefPubMedGoogle Scholar
Tan EC, George J, Stewart K, Elliott RA. Improving osteoporosis management in general practice: a pharmacist-led drug use evaluation program. Drugs Aging. 2014;31(9):703–9.CrossRefPubMedGoogle Scholar
Tan EC, Stewart K, Elliott RA, George J. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Soc Adm Pharm. 2014;10(4):608–22.CrossRefGoogle Scholar
Iversen L, Mollison J, MacLeod TN. Attitudes of the general public to the expanding role of community pharmacists: a pilot study. Fam Pract. 2001;18(5):534–6.CrossRefPubMedGoogle Scholar
Lee EL, Wong PS, Tan MY, Sheridan J. What role could community pharmacists in Malaysia play in diabetes self-management education and support? The views of individuals with type 2 diabetes. Int J Pharm Pract. 2017. https://doi.org/10.1111/ijpp.12374.Google Scholar
Nik J, Lai PS, Ng CJ, Emmerton L. A qualitative study of community pharmacists’ opinions on the provision of osteoporosis disease state management services in Malaysia. BMC Health Serv Res. 2016;16:448.CrossRefPubMedPubMedCentralGoogle Scholar
Jorgenson D, Lamb D, MacKinnon NJ. Practice change challenges and priorities: a national survey of practising pharmacists. Can Pharm J. 2011;144:125–31.CrossRefGoogle Scholar